Squarepoint
CAI

Squarepoint’s Caris Life Sciences CAI Stock Holding History

Squarepoint’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.79M Buy
+380,927
New +$6.82M 0.01% 1354
2026
Q1 		– Sell
-64,397
Closed -$1.74M – 5145
2025
Q4 		$1.74M Buy
+64,397
New +$1.81M ﹤0.01% 2162
2025
Q3 		– Sell
-77,830
Closed -$2.08M – 5155
2025
Q2 		$2.08M Buy
+77,830
New +$2.1M ﹤0.01% 2075

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Squarepoint's CAI Position: Q2 2026 in Review

Squarepoint opened a new position in Caris Life Sciences (CAI) in Q2 2026: 380,927 shares worth $6.79M. The stake represents 0.01% of the portfolio and ranks #1354 among its holdings. This is a return to the name: Squarepoint previously reported a position in CAI as recently as Q4 2025.

Squarepoint first reported a position in CAI in Q2 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Squarepoint held 380,927 shares of Caris Life Sciences worth $6.79M as of Q2 2026.
  • Caris Life Sciences was a new Squarepoint position in Q2 2026.
  • Caris Life Sciences made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1354 holding.
  • Squarepoint first reported a position in Caris Life Sciences in Q2 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.